Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Honda Motor Co., Ltd. FY2026 Earnings Call - Honda Takes JPY 1.57T EV Hit, Pivots Hard to Hybrids
Honda Motor Co., Ltd. posted a massive JPY 1.57 trillion loss for the fiscal year ended March 2026, driven almost entirely by a brutal restructuring of its EV ambitions. The company canceled three Nor...
- Honda posted a record net loss of JPY 423.9 billion for FY2026, driven by a staggering JPY 1.57 trillion in EV-related losses.
- The company canceled the launch and development of three North American EV models, recognizing JPY 1.45 trillion in impairment and loss provisions.
- Excluding EV-related losses, Honda's core business generated a healthy JPY 1.04 trillion in operating profit, with the motorcycle division hitting record highs.
- +7 more takeaways
Sempra Energy Q1 2026 Earnings Call - Oncor Rate Case Wins and Texas Infrastructure Surge
Sempra Energy delivered a solid first quarter with adjusted EPS of $1.51, beating last year's $1.44, driven by higher margins in California and a favorable Oncor rate settlement. The company affirmed ...
- Sempra Energy reported Q1 2026 adjusted EPS of $1.51, beating Q1 2025’s $1.44, with full-year guidance reaffirmed at $4.80 to $5.30.
- Oncor secured PUCT approval for a base rate review that increases the authorized return on equity to 9.75% and the equity layer to 43.5%.
- A new unit transmission modifier (UTM) allows Oncor to recover $4.4 billion in assets placed in service since January 2025, reducing regulatory lag and enabling annual filings.
- +7 more takeaways
Nexa Resources Q1 2026 Earnings Call - Silver Streaming Shift Boosts Cash Flow as Zinc Prices Surge
Nexa Resources delivered a strong start to 2026, with adjusted EBITDA more than doubling year-over-year to $283 million, driven by a constructive price environment, higher sales volumes, and improved ...
- Adjusted EBITDA surged 126% year-over-year to $283 million, with a 31.8% margin, reflecting strong price realization and operational leverage.
- Net leverage declined to 1.59 times, down from 2.09 times a year ago, supported by robust last twelve months EBITDA of $929 million.
- Zinc production rose 18% year-over-year to 79,000 tons, driven by improved ore grades across all five mines.
- +7 more takeaways
Cheniere Energy Q1 2026 Earnings Call - Upwardly Revised Guidance Amid Middle East Supply Shock
Cheniere Energy delivered a record-breaking first quarter, exporting 187 LNG cargoes and generating over $2.3 billion in adjusted EBITDA. The company raised its full-year 2026 adjusted EBITDA guidance...
- Record Q1 2026 exports of 187 LNG cargoes, surpassing the previous quarterly record set in Q4 2025.
- Full-year 2026 adjusted EBITDA guidance raised to $7.25-$7.75 billion, up from the prior range, reflecting higher production and margins.
- Distributable cash flow (DCF) guidance lifted to $4.75-$5.25 billion for 2026, driven by 1 million ton production increase and optimization gains.
- +12 more takeaways
Shinhan Financial Group Q1 2026 Earnings Call - Shinhan Upgrades Value Plan to 3.0 Plus, Targets 10%+ ROE with 50%+ Shareholder Return
Shinhan Financial Group reported a 9% year-over-year jump in Q1 2026 net income to KRW 1.62 trillion, driven by a 26.5% surge in non-interest income, particularly brokerage fees and fund sales, as cap...
- Q1 2026 net income rose 9% year-over-year to KRW 1.62 trillion, supported by a 26.5% increase in non-interest income, particularly brokerage fees (+215.2% YoY) and fund/bancassurance fees (+54.7% YoY).
- Shinhan Financial Group unveiled Shinhan Value Up 3.0 Plus, replacing its prior 10/50/50 targets with a sustainable framework focused on achieving a 10%+ ROE, 50%+ total shareholder return ratio, and maintaining a CET1 ratio above 13%.
- The group’s CET1 ratio stood at 13.19% at end-Q1, declining 68 basis points due to RWA growth and shareholder returns, but only 16 basis points from year-end, reflecting stable capital management.
- +7 more takeaways
Angel Studios Q1 2026 Earnings Call - Positive Adjusted EBITDA Driven by 72% Guild Revenue Mix
Angel Studios delivered a transformative Q1 2026, posting $115 million in revenue and $4 million in positive Adjusted EBITDA, a stark reversal from the $28 million loss in the prior year. The company’...
- Total revenue surged 143% year-over-year to $115 million, driven by a rapid shift toward recurring membership income.
- Adjusted EBITDA flipped to positive $4 million, a $32 million improvement from a $28 million loss in Q1 2025.
- The Angel Guild now represents 72% of total revenue, up from 63% in Q4 2025, signaling successful monetization of the community model.
- +7 more takeaways
Myomo Inc Q1 2026 Earnings Call - Recurring Revenue Shift and Operating Leverage Drive Profitability
Myomo Inc (MYO) delivered a first quarter that validated its strategic pivot from high-cost direct-to-patient marketing toward a recurring referral model anchored by the MyoConnect program and strateg...
- Revenue reached $10.1 million, up 3% year-over-year, driven by a 9% increase in average selling price to $58,800, partially offset by a slight decline in revenue units delivered.
- The company successfully shifted its revenue mix, with recurring patient sources accounting for 49% of Q1 revenue, a significant jump from 25% in the prior year quarter.
- Operating expenses decreased 1% year-over-year to $10.1 million, while gross margin expanded by 100 basis points to 68.2%, demonstrating early operating leverage.
- +7 more takeaways
Insight Molecular Diagnostics Q1 2026 Earnings Call - GraftAssureDx FDA Review Gains Momentum, Q2 Cash Burn Peaks at $9M
Insight Molecular Diagnostics is advancing its GraftAssureDx submission to the FDA with active engagement and expects first U.S. orders later this year. The company is building a self-funding GALACTIC...
- GraftAssureDx is in active FDA review with high engagement; first U.S. orders expected later this year.
- GALACTIC Registry enrollment has grown to 34 U.S. centers, up from 28 in six weeks, nearing the 50-center goal.
- GraftAssureCore is reimbursed by Medicare at $2,753 per result, providing a clear pricing anchor for commercial strategy.
- +7 more takeaways
Aeluma Q3 FY2026 Earnings Call - AI Datacom Demand Surges as Indium Phosphide Bottlenecks Fuel Aeluma's Non-IP Strategy
Aeluma's Q3 FY2026 results reflect a company navigating the intersection of near-term supply chain pain and long-term technological disruption. Revenue dipped slightly to $1.2 million, weighed down by...
- Revenue for Q3 FY2026 was $1.2 million, down from $1.3 million in the prior year and quarter, primarily due to delayed government contract starts.
- GAAP net loss was $1.8 million, or $0.10 per share, compared to a net income of $1.5 million in the prior year period, largely due to a one-time $2.3 million gain in derivative liabilities recorded in Q3 FY2025.
- Non-GAAP net loss was $701,000, or $0.04 per share, in line with the prior quarter, while adjusted EBITDA loss widened to $911,000 from a $109,000 gain in the prior year.
- +7 more takeaways
Sangoma Technologies Q3 FY2026 Earnings Call - Infrastructure Pivot and Strategic Review Accelerate Amid Market Shift
Sangoma Technologies is in a deliberate pivot, shifting capital and focus from a commoditizing UCaaS software business toward its growing voice and data networking infrastructure. Management highlight...
- Sangoma is redefining its business model, shifting focus from commoditized UCaaS applications to high-growth voice and data networking infrastructure, which is now the primary engine for value creation.
- Full-year FY2026 revenue guidance is lowered to CAD 204-205 million, reflecting international geopolitical disruptions, shipping cost inflation, and pricing pressure in software markets.
- The board has initiated a formal strategic review to evaluate all alternatives, including potential M&A or sale, driven by persistent market undervaluation and increased inbound interest.
- +9 more takeaways